Palivizumab e virus respiratorio sinciziale: una panoramica

Respiratory Syncytial Virus (RSV) is a very frequent cause of respiratory infections in the first two years of life. Symptoms of­ten are mild to moderate, but in some high-risk categories of infants, particularly prematures and children with bronchopulmonary dysplasia or congenital heart disease, RS...

Full description

Bibliographic Details
Main Author: Paolo Manzoni
Format: Article
Language:English
Published: SEEd Medical Publishers 2011-07-01
Series:Farmeconomia: Health Economics and Therapeutic Pathways
Subjects:
Online Access:https://journals.seedmedicalpublishers.com/index.php/FE/article/view/984